Paracetamol 500mg tablets Regno Unito - inglese - MHRA (Medicines & Healthcare Products Regulatory Agency)

paracetamol 500mg tablets

aspar pharmaceuticals ltd - paracetamol - oral tablet - 500mg

Aspirin 300mg tablets Regno Unito - inglese - MHRA (Medicines & Healthcare Products Regulatory Agency)

aspirin 300mg tablets

aspar pharmaceuticals ltd - aspirin - oral tablet - 300mg

LMX 4 cream Regno Unito - inglese - MHRA (Medicines & Healthcare Products Regulatory Agency)

lmx 4 cream

ferndale pharmaceuticals ltd - lidocaine - cutaneous cream - 40mg/1gram

Lidocaine 4% cream Regno Unito - inglese - MHRA (Medicines & Healthcare Products Regulatory Agency)

lidocaine 4% cream

colorama pharmaceuticals ltd - lidocaine - cutaneous cream - 40mg/1gram

Surgical procedure kit, general-purpose, single-use, non-medicated Australia - inglese - Department of Health (Therapeutic Goods Administration)

surgical procedure kit, general-purpose, single-use, non-medicated

schiffa health pty ltd - 33961 - surgical procedure kit, general-purpose, single-use, non-medicated - a collection of various surgical instruments, dressings and the necessary materials to perform a general-purpose surgical procedure. this device can be presented as a kit, tray or set and does not contain any pharmaceuticals. this device is disposable.

AKYNZEO Israele - inglese - Ministry of Health

akynzeo

rafa laboratories ltd - netupitant; palonosetron as hydrochloride - capsules - netupitant 300 mg; palonosetron as hydrochloride 0.50 mg - palonosetron, combinations - prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of cancer chemotherapy, including, but not limited to, highly emetogenic chemotherapy.

VENCLEXTA 10 MG TABLETS Israele - inglese - Ministry of Health

venclexta 10 mg tablets

abbvie biopharmaceuticals ltd, israel - venetoclax - film coated tablets - venetoclax 10 mg - venetoclax - chronic lymphocytic leukemia/small lymphocytic lymphomavenclexta in combination with rituximab or as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukaemia (cll) or small lymphocytic lymphoma (sll), who have received at least one prior therapy.venclexta in combination with obinutuzumab is indicated for the treatment of patients with previously untreated chronic lymphocytic leukaemia (cll) or small lymphocytic lymphoma (sll).acute myeloid leukemiavenclexta in combination with a hypomethylating agent or in combination with low dose cytarabine is indicated for newly diagnosed patients with acute myeloid leukemia (aml) who are ineligible for intensive chemotherapy.

VENCLEXTA 100 MG TABLETS Israele - inglese - Ministry of Health

venclexta 100 mg tablets

abbvie biopharmaceuticals ltd, israel - venetoclax - film coated tablets - venetoclax 100 mg - venetoclax - chronic lymphocytic leukemia/small lymphocytic lymphomavenclexta in combination with rituximab or as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukaemia (cll) or small lymphocytic lymphoma (sll), who have received at least one prior therapy.venclexta in combination with obinutuzumab is indicated for the treatment of patients with previously untreated chronic lymphocytic leukaemia (cll) or small lymphocytic lymphoma (sll).acute myeloid leukemiavenclexta in combination with a hypomethylating agent or in combination with low dose cytarabine is indicated for newly diagnosed patients with acute myeloid leukemia (aml) who are ineligible for intensive chemotherapy.

VENCLEXTA 50 MG TABLETS Israele - inglese - Ministry of Health

venclexta 50 mg tablets

abbvie biopharmaceuticals ltd, israel - venetoclax - film coated tablets - venetoclax 50 mg - venetoclax - chronic lymphocytic leukemia/small lymphocytic lymphomavenclexta in combination with rituximab or as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukaemia (cll) or small lymphocytic lymphoma (sll), who have received at least one prior therapy.venclexta in combination with obinutuzumab is indicated for the treatment of patients with previously untreated chronic lymphocytic leukaemia (cll) or small lymphocytic lymphoma (sll).acute myeloid leukemiavenclexta in combination with a hypomethylating agent or in combination with low dose cytarabine is indicated for newly diagnosed patients with acute myeloid leukemia (aml) who are ineligible for intensive chemotherapy.

LEDAGA Israele - inglese - Ministry of Health

ledaga

rafa laboratories ltd - chlormethine as hydrochloride - gel - chlormethine as hydrochloride 160 mcg/g - chlormethine - topical treatment of stage ia and ib mycosis fungoides-type cutaneous t-cell lymphoma in patients who have received prior skin-directed therapy